
The decision to take medications for an arrhythmia is an important one, and depends on the type of rhythm disturbance, the severity of symptoms, and the associated risk of complications. That determination should be discussed thoroughly with an experienced provider.
It’s not unusual for the heart to skip every now and then with the occasional palpitation. But there are times when heart rhythm disturbances aren’t so normal, as in more serious conditions like tachycardia (fast heart rate), bradycardia (slow heart rate), and fibrillation, which involves rapid, uncoordinated heart activity.
Although they aren’t considered normal, they also aren’t uncommon. Arrhythmias (irregular heart rhythms) affect millions of people in the United States, with atrial fibrillation alone affecting over 5 million individuals.1-2
Treatment depends on both the type of arrhythmia and the risks that come with it. In many cases, management includes medications such as antiarrhythmics, which help control the heart’s rhythm, and anticoagulants, which reduce the risk of blood clots and stroke. Both are commonly used, they serve very different purposes, and are often used together rather than interchangeably.
Antiarrhythmics
Medications are introduced when symptoms interfere with daily life, when lifestyle changes alone are not enough, when arrhythmias occur frequently or persist over time, or when there is a risk of more serious complications such as heart failure or cardiac arrest.
Antiarrhythmics are medications that control or stabilize abnormal heart rhythms when the heart’s electrical system isn’t functioning properly and causes the heart to beat too fast, too slow, or irregularly. This class of medications works by affecting the heart’s electrical signaling by slowing abnormal impulses down or blocking extra or rapid signals from traveling through the heart. The intentional interference the medication creates restores a more normal rhythm or prevents episodes of irregular heartbeats from occurring.
There are different types of arrhythmias, and no single antiarrhythmic medication works for everyone. Treatment is individualized, and finding the right medication may take time and close monitoring with a healthcare provider. Ongoing follow-up and monitoring with electrocardiograms (ECGs) or Holter monitoring will assess how well the medication is working and whether adjustments are needed.
Anticoagulants
Anticoagulants are medications that reduce the blood’s ability to clot. These do not treat an abnormal heart rhythm itself; they’re used to reduce the risk of stroke and other complications caused by blood clots in certain types of arrhythmias. Anticoagulants do not dissolve existing blood clots; they only prevent them from forming in the first place or getting any bigger.
Atrial fibrillation (AFib) is an arrhythmia that commonly calls for the use of anticoagulants. In AFib, the upper chambers of the heart do not contract effectively, which leads to slower blood flow and can allow blood to pool inside the heart. When blood pools, clots can form, and these clots may travel to the brain and cause a stroke. The decision to use anticoagulation is based on individual stroke risk rather than the presence of atrial fibrillation alone.
Scoring tools, such as CHA₂DS₂-VASc, are used to estimate stroke vulnerability and determine whether the benefits of anticoagulation outweigh the risks. Not everyone with atrial fibrillation will automatically be prescribed an anticoagulant. However, even when heart rhythm is restored or controlled, anticoagulation may still be recommended in some patients, because atrial fibrillation can come and go without noticeable symptoms, meaning stroke risk can still be present even if the arrhythmia is not actively felt.
Shared Decisions
Antiarrhythmics and anticoagulants address different problems: one targets the heart’s electrical impulses to restore a healthier rhythm in conditions like supraventricular tachycardia (SVT), AFib, and certain ventricular arrhythmias, while the other reduces the risk of stroke due to the blood pooling that happens with an arrhythmia, primarily AFib.
The decision to use medications is based on balancing the complications of living with an abnormal heart rhythm and susceptibility to blood clotting and stroke with the benefits the medications provide.
Because anticoagulant medications reduce clotting ability, they also increase the risk of bleeding. Discussing what that looks like in daily life is part of the decision-making process: avoiding high-impact or contact activities that increase the chance of injury, using caution with sharp objects, and monitoring for easy bruising or prolonged bleeding will be new habits to get used to. It is also important to review all medications and supplements with a healthcare provider, since some over-the-counter products (such as fish oil, certain herbal supplements, or high-dose vitamin E) may further increase bleeding risk or interact with anticoagulants.
With antiarrhythmic medications, decision-making also involves safety considerations and lifestyle factors. Patients are advised to limit caffeine, alcohol, and stimulant-containing medications since these are known triggers for arrhythmias. Other drugs can also affect the heart rhythm, and adding antiarrhythmics to your routine without discussing the rest of the medications and supplements you take, even if occasionally, can lead to unwanted or dangerous adverse reactions. Some combinations can increase the risk of abnormal heart rhythms or reduce the effectiveness of treatment. Proarrhythmia can also happen, which is when medications can actually worsen existing arrhythmias or cause new abnormal heart rhythms.
Some arrhythmias are brief, infrequent, and asymptomatic, and may not require medication at all. Other arrhythmias, such as supraventricular tachycardia (SVT), may require treatment with antiarrhythmic medications or procedures to control episodes, but typically not anticoagulants. Even when obvious rhythm symptoms are minimal or absent, the recommendation for atrial fibrillation might still include anticoagulant therapy. Testing, reporting, sharing medication lists and lifestyle habits all help build a decision matrix with your provider so you can arrive at the best combination of therapies for your unique situation.
Note: Aspirin and other antiplatelet medications are not considered effective for preventing stroke in atrial fibrillation. Always discuss the use of all medications, both prescription and over-the-counter, with your healthcare provider, as some combinations can have harmful interactions.
Dr. Andrea Tordini is a board-certified cardiac electrophysiologist with specialized fellowship training in diagnosing and treating abnormal heart rhythms.
Dr. Tordini is a part of Florida Medical Clinic Orlando Health
References
- Khurshid, S., Choi, S. H., Weng, L. C., Wang, E. Y., Trinquart, L., Benjamin, E. J., Ellinor, P. T., & Lubitz, S. A. (2018). Frequency of Cardiac Rhythm Abnormalities in a Half Million Adults. Circulation. Arrhythmia and electrophysiology, 11(7), e006273. https://doi.org/10.1161/CIRCEP.118.006273.
- American Heart Association. (2025, March 26). What is Atrial Fibrillation? Www.heart.org. https://www.heart.org/en/health-topics/atrial-fibrillation/what-is-atrial-fibrillation-afib-or-af.